A fraction of acal5 mutant embryos exhibit dorsal closure defects, with holes in either the dorsal or anterior ends of the embryo. No other cuticular defects are seen.
lncRNA:acal5 has lethal phenotype, enhanceable by raw2
lncRNA:acal5 has some die during embryonic stage phenotype, enhanceable by raw2
lncRNA:acal5 has lethal phenotype, suppressible | partially by aop1
lncRNA:acal5 has some die during embryonic stage phenotype, suppressible | partially by aop1
lncRNA:acal5 has lethal phenotype, suppressible | partially by bsk1
lncRNA:acal5 has some die during embryonic stage phenotype, suppressible | partially by bsk1
acal[+]/lncRNA:acal5 is a suppressor of lethal - all die before end of embryonic stage phenotype of aop1
lncRNA:acal5/lncRNA:acal5 is a non-suppressor of lethal phenotype of raw2
lncRNA:acal5/lncRNA:acal5 is a non-suppressor of majority die during embryonic stage phenotype of raw2
acal[+]/lncRNA:acal5 is a non-suppressor of lethal phenotype of bsk1
acal[+]/lncRNA:acal5 is a non-suppressor of some die during embryonic stage phenotype of bsk1
acal[+]/lncRNA:acal5 is a non-suppressor of lethal phenotype of raw2
acal[+]/lncRNA:acal5 is a non-suppressor of majority die during embryonic stage phenotype of raw2
acal[+]/lncRNA:acal5, aop1 has some die during embryonic stage phenotype
lncRNA:acal5 has embryonic/larval cuticle phenotype, suppressible | partially by aop1
acal[+]/lncRNA:acal5 is a suppressor | partially of embryonic/larval cuticle phenotype of aop1
lncRNA:acal5/lncRNA:acal5 is a non-suppressor of embryonic/larval cuticle phenotype of raw2
acal[+]/lncRNA:acal5 is a non-suppressor of embryonic/larval cuticle phenotype of raw2
bsk1 significantly suppresses the dorsal closure defects and lethality seen in homozygous acal5 mutant embryos.
One copy of acal5 does not suppress the dorsal closure defects and lethality seen in homozygous bsk1 mutant embryos.
One copy of raw2 enhances the embryonic lethality seen in homozygous acal5 mutants, with a quarter of embryos phenocopying the dorsalized phenotype seen in raw2 alone. acal5 does not enhance the homozygous raw2 phenotype.
One copy of acal5 almost completely rescues the dorsal closure defects and lethality seen in aop1 mutant embryos.
One copy of aop1 does not rescue the dorsal closure defects and lethality seen in acal5 mutant embryos.
lncRNA:acal5 is partially rescued by lncRNA:acalUAS.cRa/Scer\GAL469B
Expression of acalScer\UAS.cRa under the control of Scer\GAL469B results in significant rescue of acal5 dorsal closure defects and reduction of embryonic lethality.
Expression of acalScer\UAS.cRa under the control of Scer\GAL4pnr-MD237 rescues acal5 dorsal closure defects.